Goodman Advisory Group’s GSK GSK Stock Holding History

Goodman Advisory Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-121	Closed	-$4.39K	–	163
2023 Q3	$4.39K	Buy	+121	New	+$4.29K	﹤0.01%	137

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goodman Advisory Group's GSK Position: Q4 2023 in Review

Goodman Advisory Group sold out of GSK (GSK) in Q4 2023, closing a stake of 121 shares — an estimated $4.39K sold.

Goodman Advisory Group first reported a position in GSK in Q3 2023 and held it in 1 quarter. The position peaked at $4.39K in Q3 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

Goodman Advisory Group reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
Goodman Advisory Group sold 121 GSK shares in Q4 2023, an estimated $4.39K.
Goodman Advisory Group first reported a position in GSK in Q3 2023 and held it in 1 quarter.
Goodman Advisory Group's GSK position peaked at $4.39K in Q3 2023.
895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Goodman Advisory Group's 13F filing for Q4 2023, filed 31 Jan 2024.